Efficacy and Safety of Jia Shen Tablets in Chronic Heart Failure
A phase 2 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 288 participants.
Also called NCT06669169
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 288 participants
- Registry
-
NCT06669169
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT06669169. Randomized; quadruple masking; primary purpose treatment. Start 2025-01-31 (anticipated); primary completion 2026-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of Jia Shen Tablets in Chronic Heart Failure
- Condition
- Heart Failure
- Intervention (Drug)
- Jia Shen Tablet Placebo
- Intervention (Drug)
- Low dose Jia Shen Tablet
- Intervention (Drug)
- High dose Jia Shen Tablet
- Lead sponsor
- Tasly Pharmaceutical Group Co., Ltd
Record details
- Record id
cardio:ct-nct06669169- Content hash
78ca290801ce01a0678e8fce1c20132777f5d6da8ec01f3cba44ce3da5952d9a